{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T04:20:40Z","timestamp":1684556440754},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T00:00:00Z","timestamp":1370304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1038\/nrneph.2013.104","type":"journal-article","created":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T11:27:11Z","timestamp":1370345231000},"page":"377-379","source":"Crossref","is-referenced-by-count":1,"title":["The price of a QALY\u2014cost-effectiveness of statins in CKD"],"prefix":"10.1038","volume":"9","author":[{"given":"Vivekanand","family":"Jha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopesh K.","family":"Modi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,4]]},"reference":[{"key":"BFnrneph2013104_CR1","unstructured":"United States Renal Data System. 2012 USRDS Annual Data Report: atlas of chronic kidney disease and end-stage renal disease in the United States. United States Renal Data System \n                    [online]\n                    \n                  , (2012)."},{"key":"BFnrneph2013104_CR2","doi-asserted-by":"crossref","unstructured":"Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375, 2073\u20132081 (2010).","DOI":"10.1016\/S0140-6736(10)60674-5"},{"key":"BFnrneph2013104_CR3","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S0140-6736(12)60572-8","volume":"380","author":"M Tonelli","year":"2012","unstructured":"Tonelli, M.  et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet 380, 807\u2013814 (2012).","journal-title":"Lancet"},{"key":"BFnrneph2013104_CR4","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1161\/CIRCULATIONAHA.110.986349","volume":"124","author":"LD Lazar","year":"2011","unstructured":"Lazar, L. D., Pletcher, M. J., Coxson, P. G., Bibbins-Domingo, K. & Goldman, L. Cost-effectiveness of statin therapy for primary prevention in a low-cost statin era. Circulation 124, 146\u2013153 (2011).","journal-title":"Circulation"},{"key":"BFnrneph2013104_CR5","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.jacc.2012.12.034","volume":"61","author":"KF Erickson","year":"2013","unstructured":"Erickson, K. F.  et al. Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease. J. Am. Coll. Cardiol. 61, 1250\u20131258 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrneph2013104_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1586\/14737167.8.2.165","volume":"8","author":"SD Grosse","year":"2008","unstructured":"Grosse, S. D. Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold. Expert Rev. Pharmacoecon. Outcomes Res. 8, 165\u2013178 (2008).","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"BFnrneph2013104_CR7","doi-asserted-by":"publisher","first-page":"f1049","DOI":"10.1136\/bmj.f1049","volume":"346","author":"D Husereau","year":"2013","unstructured":"Husereau, D.  et al. Consolidated health economic evaluation reporting standards (CHEERS) statement. BMJ 346, f1049 (2013).","journal-title":"BMJ"},{"key":"BFnrneph2013104_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/(SICI)1099-1050(199902)8:1<25::AID-HEC398>3.0.CO;2-H","volume":"8","author":"E Nord","year":"1999","unstructured":"Nord, E., Pinto, J. L., Richardson, J., Menzel, P. & Ubel, P. Incorporating societal concerns for fairness in numerical valuations of health programmes. Health Econ. 8, 25\u201339 (1999).","journal-title":"Health Econ."},{"key":"BFnrneph2013104_CR9","unstructured":"Jha, V.  et al. Chronic kidney disease: global dimension and perspectives. Lancet (in press)."},{"key":"BFnrneph2013104_CR10","first-page":"191","volume":"1","author":"A Oliver","year":"2002","unstructured":"Oliver, A. Accounting for the missing opportunity costs in incremental cost-outcome analysis. Appl. Health Econ. Health Policy 1, 191\u2013196 (2002).","journal-title":"Appl. Health Econ. Health Policy"}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2013.104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2013.104","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2013.104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:40:26Z","timestamp":1684471226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2013.104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,4]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["BFnrneph2013104"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2013.104","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,4]]}}}